Vivos Therapeutics, Inc. announced a private placement of 169,498 common shares at a price of $2.329 per share for the gross proceeds of CAD 394,760.842, a pre-funded warrant to purchase 3,050,768 shares of Common Stock and warrants for the gross proceeds of $7,500,000 on June 10, 2024. The warrants will be exercisable into 3,220,266 shares at a price of $2.204 per share. The Common Stock Purchase Warrant has a five year term, an exercise price of $2.204 per share and became exercisable immediately as of the date of issuance.

The Pre-Funded Warrant has a term ending on the complete exercise of the Pre-Funded Warrant, an exercise price of $0.0001 per share. The transaction included participation from V-CO Investors LLC, an affiliate of New Seneca Partners Inc. Seneca has also been provided with company's board of directors observation rights.